Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy.
Dutra-Clarke M, Tapia D, Curtin E, Rünger D, Lee GK, Lakatos A, Alandy-Dy Z, Freedkin L, Hall K, Ercelen N, Alandy-Dy J, Knight M, Pahl M, Lombardo D, Kimonis V.
Dutra-Clarke M, et al. Among authors: runger d.
Mol Genet Metab Rep. 2020 Dec 31;26:100700. doi: 10.1016/j.ymgmr.2020.100700. eCollection 2021 Mar.
Mol Genet Metab Rep. 2020.
PMID: 33437642
Free PMC article.